Loading the security overview…
Where the tokens are
Standardised from the company’s filings, newest period first, labelled with the company’s own fiscal calendar. A line the company does not report is left off rather than shown as zero; margins and free cash flow are worked out here, and only where every input is present.
| Line item | Q2 FY262026-06-30 | Q1 FY262026-03-31 | Q4 FY252025-12-31 | Q3 FY252025-09-30 | Q2 FY252025-06-30 | Q1 FY252025-03-31 | Q4 FY242024-12-31 | Q3 FY242024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.60B | $1.59B | $1.54B | $1.48B | $1.46B | $1.46B | $1.41B | $1.35B |
| Gross profit | $1.60B | $1.59B | $1.54B | $1.48B | $1.46B | $1.46B | $1.41B | $1.35B |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Selling, general and administrative | $882.90M | $876.30M | $869.50M | $840.90M | $827.10M | $814.60M | $811.30M | $786.10M |
| Operating expenses | $1.31B | $1.29B | $1.26B | $1.23B | $1.20B | $1.19B | $1.17B | $1.14B |
| Operating income | $288.40M | $301.60M | $283.40M | $243.60M | $259.10M | $267.00M | $232.30M | $209.10M |
| Operating margin | 18.1% | 19.0% | 18.3% | 16.5% | 17.8% | 18.3% | 16.5% | 15.5% |
| EBITDA | $469.20M | $388.90M | $369.80M | $326.00M | $418.90M | $346.20M | $310.30M | $287.50M |
| Interest expense | −$32.80M | −$31.80M | −$30.20M | −$30.80M | −$30.40M | −$31.80M | −$33.00M | −$34.90M |
| Income before taxes | $261.60M | $288.70M | $257.70M | $219.90M | $236.80M | $238.60M | $201.40M | $183.80M |
| Income taxes | $53.60M | $56.40M | $55.40M | $44.90M | $51.00M | $41.60M | $37.60M | $36.00M |
| Net income | $207.40M | $248.20M | $203.10M | $174.60M | $184.90M | $196.50M | $164.20M | $147.10M |
| Net margin | 13.0% | 15.6% | 13.1% | 11.8% | 12.7% | 13.5% | 11.7% | 10.9% |
| EPS, basic | $1.55 | $1.96 | $1.44 | $1.26 | $1.41 | $1.50 | $1.18 | $1.08 |
| EPS, diluted | $1.54 | $1.93 | $1.42 | $1.24 | $1.39 | $1.48 | $1.15 | $1.06 |
| Diluted shares | 100.00M | 100.60M | 102.10M | 102.30M | 102.30M | 102.10M | 102.50M | 102.10M |
Figures describe Encompass Health shares, not any token. As of Aug 7, 2026, from Massive's standardised financials. The company reports these figures; a token's issuer holds the shares and reports nothing of its own here.